FDA Extends Deadline for Submitting DMFs in eCTD format

NDAs, BLAs, and ANDAs eSubmission deadline is maintained for next May 5th 2017

NDAs, BLAs, and ANDAs eSubmission deadline is maintained for next May 5th 2017
April 19, 2017
On April 7th 2017, the FDA announced, in response to industry comments and internal review, that is postponing by one year the compliance date for submitting drug master files (DMFs) in electronic common technical document (eCTD) format. Current deadline for submitting DMFs in eCTD format is May 5, 2018.
In order to reflect this change in the timeline, FDA has published Revision 4 of the Guidance for Industry: Providing Regulatory Submissions in Electronic Format – Certain Human Pharmaceutical Product Applications and Related Submissions Using the eCTD Specifications. The compliance date for submitting NDAs, BLAs, and ANDAs electronically remains unchanged. 
ASPHALION has extensive experience in transmitting electronic submissions using eCTD specifications. If you need any support to comply with FDA requirements, please contact us: info@asphalion.com

Search News & Events

  • Filter by category


Related news and events

Christmas season greatings

Season’s Greetings

We wish you Happy ‘Xmas, Prosperous New Year and Health for you and your loved ones.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting